⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2000Pharmacogenetics

Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Miners, John O.; Coulter, Sally; Birkett, Donald J.; Goldstein, Joyce A. Author Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Miners et al. (2000) studied this question.

synapsesocial.com/papers/6a856b55ee60e6e86dae5db2 https://doi.org/10.1097/00008571-200004000-00008

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of Residues 99, 220, and 221 of Human Cytochrome P450 2C19 as Key Determinants of Omeprazole Hydroxylase ActivityOriginal Research · 1996 · 88 citations
2Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy*Original Research · 1997 · 154 citations
3INVERTED RESPONSE OF ARGININE VASOPRESSIN TO POSTURAL CHANGE IN PATIENTS WITH ESSENTIAL HYPERTENSIONOriginal Research · 1982 · 11 citations
4Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9Original Research · 1994 · 489 citations
5Genetic analysis of the human cytochrome P450 CYP2C9 locusOriginal Research · 1996 · 304 citations